VIR Should I Buy

Vir Biotechnology Inc (VIR) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock's technical indicators show some bullish momentum, but the financial performance is significantly weak, with declining revenue, net income, and EPS. Additionally, hedge funds are selling heavily, and there are no recent positive news or significant catalysts to support a strong upward trend. The options data indicates a bearish sentiment with a low Put-Call ratio and high implied volatility, suggesting uncertainty. Analysts maintain a Buy rating but have lowered the price target, reflecting cautious optimism. Given these factors, holding off on buying this stock is the most prudent decision.

The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 77.482, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 7.436), with the next resistance at R2: 7.922. However, the stock's probability of decline in the next day, week, and month is significant (-1.98%, -3.47%, -1.84%).